A closer look at severe acute kidney injury: risk factors and outcomes in PD-1/PD-L1 antibody treatment from a retrospective study
This study highlights the importance of monitoring these factors to reduce the risk of severe AKI in patients receiving PD-1/PD-L1 antibody therapy.
Authors
- Wei Zhang (ORCID: https://orcid.org/0000-0001-5292-7308)
- Liping Luo (ORCID: https://orcid.org/0000-0002-5649-1289)
- Xiaolan Ye (ORCID: https://orcid.org/0000-0001-7620-9642)
- Shuangshan Bu (ORCID: https://orcid.org/0000-0002-8568-9569)
- Xin Sun (ORCID: https://orcid.org/0000-0002-6453-850X)
- Yan Ren (ORCID: https://orcid.org/0000-0003-1672-3687)
- Yiwen Li (ORCID: https://orcid.org/0000-0002-7390-6992)
- Yuemeng Wu
- Bin Zhu (ORCID: https://orcid.org/0000-0003-0249-4254)
- Lina Shao (ORCID: https://orcid.org/0000-0002-2857-8774)
Institutions
- Wenzhou Medical University (CN)
- Affiliated Hospital of Hangzhou Normal University (CN)
- Zhejiang Provincial People's Hospital (CN)
- Dongyang People's Hospital (CN)
- Hangzhou Medical College (CN)
Publication Details
- Journal
- PeerJ
- Published
- 2025-08-26
- DOI
- https://doi.org/10.7717/peerj.19886
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province